-transparent.png){kind=logo}
The affinity for eight different neurotransmitter receptors of about forty drugs, used for the treatment of various central nervous system disorders, was determined following in vitro receptor binding assays. Our findings indicate that, in spite of widely varying chemical structures and often poorly understood mechanisms of action, the similarities in the "affinity profiles" permit a clinically meaningful classification of these drugs. Such an approach would thus be useful in the assessment of newly synthesized compounds at an early stage of drug development.
Related Publications
A Closse, and
W Frick, and
A Dravid, and
G Bolliger, and
D Hauser, and
A Sauter, and
H J Tobler
August 1991,
Ugeskrift for laeger,
A Closse, and
W Frick, and
A Dravid, and
G Bolliger, and
D Hauser, and
A Sauter, and
H J Tobler
January 2018,
Current neuropharmacology,
A Closse, and
W Frick, and
A Dravid, and
G Bolliger, and
D Hauser, and
A Sauter, and
H J Tobler
March 2013,
Journal of medicine and life,
A Closse, and
W Frick, and
A Dravid, and
G Bolliger, and
D Hauser, and
A Sauter, and
H J Tobler
June 1972,
Monatsschrift fur Kinderheilkunde,
A Closse, and
W Frick, and
A Dravid, and
G Bolliger, and
D Hauser, and
A Sauter, and
H J Tobler
January 1997,
Archivum immunologiae et therapiae experimentalis,
A Closse, and
W Frick, and
A Dravid, and
G Bolliger, and
D Hauser, and
A Sauter, and
H J Tobler
September 2010,
The Journal of clinical psychiatry,
A Closse, and
W Frick, and
A Dravid, and
G Bolliger, and
D Hauser, and
A Sauter, and
H J Tobler
July 1974,
Federation proceedings,
A Closse, and
W Frick, and
A Dravid, and
G Bolliger, and
D Hauser, and
A Sauter, and
H J Tobler
January 1986,
Anticancer research,
A Closse, and
W Frick, and
A Dravid, and
G Bolliger, and
D Hauser, and
A Sauter, and
H J Tobler
November 2010,
European journal of medicinal chemistry,
A Closse, and
W Frick, and
A Dravid, and
G Bolliger, and
D Hauser, and
A Sauter, and
H J Tobler
January 2020,
Chem,
